News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Updates on the Management of Advanced Paediatric Hodgkin Lymphoma – SIOP
SIOP/LinkedIn
Mar 5, 2025, 06:57

Updates on the Management of Advanced Paediatric Hodgkin Lymphoma – SIOP

SIOP shared a post on LinkedIn:

“Join us for the next DiSPLeN webinar on Updates on the Management of Advanced Paediatric Hodgkin Lymphoma.

TOMORROW March 5, 2025, at 16:00 CET!
Don’t miss out, open to everyone – register today!
Watch previous DiSPLeN webinars.”

Paediatric Hodgkin Lymphoma

cancer OncoDaily Oncology Paediatric Hodgkin Lymphoma SIOP
Special Coverage
Blog Posts
Aug 15, 2025, 11:43
Naveen Pemmaraju: 2025 Annual MPN Workshop of the Carolinas is Coming Up Soon
Career Updates
Aug 15, 2025, 11:32
Howard Jack West Applauds Alice Shaw’s Appointment as Chair of Medical Oncology
Insight
Aug 15, 2025, 11:31
Ezra Cohen Highlights Sequential SBRT and Anti-PD1 Strategy in Lung Cancer
Voices
Aug 15, 2025, 11:27
Robert Timmerman: How Expert Care and Resilience Can Defy the Odds
Voices
Aug 15, 2025, 11:22
Dean Crowe: Turning Awareness into Action for Childhood Cancer in Georgia
Voices
Aug 15, 2025, 11:15
Ruben Mesa Congratulates Joshua Patt on Endowed Chair Appointment in Sarcoma Research
Voices
Aug 15, 2025, 11:11
Practical Guide to Boost Lung Cancer Screening in Primary Care - ACS NLCRT
Insight
Aug 15, 2025, 11:08
Richard Sullivan Announces Release of Handbook of Global Health, Security, and War
Insight
Aug 15, 2025, 11:07
Aisling Barry: The Role of RT in Liver and Gall Bladder Cancers
Science
Aug 15, 2025, 11:04
Angela Mastronuzzi Highlights Link Between Early Radiologic Response and Prognosis in Children with NF1
Voices
Aug 15, 2025, 10:31
Record $2B Gift to Transform Cancer Care at OHSU Knight Cancer Institute
Voices
Aug 15, 2025, 10:05
Eric Whitman: FDA’s Rejection of RP1 by Replimune